Treatment of pediatric refractory or relapsed Epstein–Barr virus‐associated hemophagocytic syndrome with PD‐1 inhibitors

Ähnliche Einträge

• Epstein–Barr virus‐associated smooth muscle tumor in a female with ataxia telangiectasia: A case report
  von: Beatrice Rivalta, et al.
  Veröffentlicht: (2024)
• Epstein–Barr virus monitoring for preemptive re‐hematopoietic cell transplantation in CD3δ‐deficient siblings
  von: Sungyeon Park, et al.
  Veröffentlicht: (2024)
• Incorporating innovative B‐cell targeting therapeutics into a combined‐modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B‐cell lymphoma
  von: Yu‐Ju Chao, et al.
  Veröffentlicht: (2024)
• Systemic Epstein–Barr Virus–Positive T‐Cell Lymphoma of Childhood: A Case Series
  von: Maiah Zarrabi, et al.
  Veröffentlicht: (2026)
• Rare Findings of Spleen Lesions Secondary to Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Children
  von: Zhengli Shan, et al.
  Veröffentlicht: (2025)